{
    "General": {
        "Code": "260",
        "Type": "Common Stock",
        "Name": "CENTESSA PHARMACEUTICALS",
        "Exchange": "F",
        "CurrencyCode": "EUR",
        "CurrencyName": "Euro",
        "CurrencySymbol": "\u20ac",
        "CountryName": "Germany",
        "CountryISO": "DE",
        "OpenFigi": null,
        "ISIN": "US1523091007",
        "LEI": null,
        "PrimaryTicker": null,
        "CIK": null,
        "EmployerIdNumber": null,
        "FiscalYearEnd": "December",
        "IPODate": null,
        "InternationalDomestic": null,
        "Sector": "Healthcare",
        "Industry": "Biotechnology",
        "GicSector": "Health Care",
        "GicGroup": "Pharmaceuticals, Biotechnology & Life Sciences",
        "GicIndustry": "Biotechnology",
        "GicSubIndustry": "Biotechnology",
        "Description": "Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its pipeline products include SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of NT1 with potential expansion into other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; ZF874 in alpha-1 antitrypsin deficiency, a dual-STAT3/5 degrader program in acute myeloid leukemia (AML); MGX292, a protein-engineered variant of human bone morphogenetic protein 9 (BMP9) for the treatment of pulmonary arterial hypertension (PAH); and OX2R Agonists compounds are currently in development for the treatment of narcolepsy, including TAK-861. In addition, its products pipeline comprises CBS001, a neutralizing therapeutic mAb to the inflammatory membrane form of LIGHT for inflammatory / fibrotic diseases; and CBS004, a therapeutic mAb targeting BDCA-2 for the potential treatment of autoimmune diseases, as well as earlier-stage preclinical assets, including ORX750, an orally administered, selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and discovery-stage programs in certain other disease areas. Centessa Pharmaceuticals plc was incorporated in 2020 and is based in Altrincham, the United Kingdom.",
        "Address": null,
        "AddressData": null,
        "Listings": {},
        "Officers": {},
        "Phone": null,
        "WebURL": null,
        "LogoURL": "",
        "FullTimeEmployees": 64,
        "UpdatedAt": "2023-08-31"
    },
    "Highlights": {
        "MarketCapitalization": 637724992,
        "MarketCapitalizationMln": 637.725,
        "EBITDA": -183130000,
        "PERatio": null,
        "PEGRatio": null,
        "WallStreetTargetPrice": 38.67,
        "BookValue": 2.902,
        "DividendShare": 0,
        "DividendYield": 0,
        "EarningsShare": -1.67,
        "EPSEstimateCurrentYear": -2.22,
        "EPSEstimateNextYear": -2.89,
        "EPSEstimateNextQuarter": 0,
        "EPSEstimateCurrentQuarter": -0.55,
        "MostRecentQuarter": "2023-06-30",
        "ProfitMargin": 0,
        "OperatingMarginTTM": 0,
        "ReturnOnAssetsTTM": -0.251,
        "ReturnOnEquityTTM": -0.4957,
        "RevenueTTM": 0,
        "RevenuePerShareTTM": 0,
        "QuarterlyRevenueGrowthYOY": 0,
        "GrossProfitTTM": 0,
        "DilutedEpsTTM": -1.67,
        "QuarterlyEarningsGrowthYOY": 0
    },
    "Valuation": {
        "TrailingPE": 0,
        "ForwardPE": 0,
        "PriceSalesTTM": 0,
        "PriceBookMRQ": 0,
        "EnterpriseValue": 344258080,
        "EnterpriseValueRevenue": 0,
        "EnterpriseValueEbitda": 0
    },
    "SharesStats": {
        "SharesOutstanding": 97402896,
        "SharesFloat": 29854977,
        "PercentInsiders": 1.9060000000000001,
        "PercentInstitutions": 80.547,
        "SharesShort": null,
        "SharesShortPriorMonth": null,
        "ShortRatio": null,
        "ShortPercentOutstanding": null,
        "ShortPercentFloat": null
    },
    "Technicals": {
        "Beta": 1.2727,
        "52WeekHigh": 7.05,
        "52WeekLow": 2.72,
        "50DayMA": 5.8946,
        "200DayMA": 4.0984,
        "SharesShort": 0,
        "SharesShortPriorMonth": 0,
        "ShortRatio": 0,
        "ShortPercent": 0
    },
    "SplitsDividends": {
        "ForwardAnnualDividendRate": 0,
        "ForwardAnnualDividendYield": 0,
        "PayoutRatio": 0,
        "DividendDate": null,
        "ExDividendDate": null,
        "LastSplitFactor": null,
        "LastSplitDate": null,
        "NumberDividendsByYear": {}
    },
    "Holders": null,
    "InsiderTransactions": {},
    "outstandingShares": {
        "annual": {},
        "quarterly": {}
    },
    "Earnings": {
        "History": {
            "2021-06-30": {
                "reportDate": "2021-06-30",
                "date": "2021-06-30",
                "beforeAfterMarket": null,
                "currency": null,
                "epsActual": -0.65,
                "epsEstimate": -0.66,
                "epsDifference": 0.01,
                "surprisePercent": 1.5152
            }
        },
        "Trend": {
            "2022-12-31": {
                "date": "2022-12-31",
                "period": "+1y",
                "growth": "-0.3020",
                "earningsEstimateAvg": "-2.8900",
                "earningsEstimateLow": "-3.2200",
                "earningsEstimateHigh": "-2.2600",
                "earningsEstimateYearAgoEps": "-2.2200",
                "earningsEstimateNumberOfAnalysts": "3.0000",
                "earningsEstimateGrowth": "-0.3020",
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "3.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "-2.8900",
                "epsTrend7daysAgo": "-2.8900",
                "epsTrend30daysAgo": "-2.8900",
                "epsTrend60daysAgo": "-2.7400",
                "epsTrend90daysAgo": "0.0000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2021-12-31": {
                "date": "2021-12-31",
                "period": "0y",
                "growth": null,
                "earningsEstimateAvg": "-2.2200",
                "earningsEstimateLow": "-2.7700",
                "earningsEstimateHigh": "-1.8400",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "3.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "3.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "-2.2200",
                "epsTrend7daysAgo": "-2.2200",
                "epsTrend30daysAgo": "-2.2200",
                "epsTrend60daysAgo": "-2.2900",
                "epsTrend90daysAgo": "0.0000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2021-09-30": {
                "date": "2021-09-30",
                "period": "0q",
                "growth": null,
                "earningsEstimateAvg": "-0.5500",
                "earningsEstimateLow": "-0.7300",
                "earningsEstimateHigh": "-0.4600",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "3.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "1.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "-0.5500",
                "epsTrend7daysAgo": "-0.5500",
                "epsTrend30daysAgo": "-0.5500",
                "epsTrend60daysAgo": "-0.5400",
                "epsTrend90daysAgo": "0.0000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            }
        },
        "Annual": {
            "2021-06-30": {
                "date": "2021-06-30",
                "epsActual": -0.65
            }
        }
    },
    "Financials": {
        "Balance_Sheet": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Cash_Flow": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Income_Statement": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        }
    }
}